Data from a single center in Bangladesh demonstrated a remarkable reduction in bleeding among people with hemophilia with and without inhibitors to FVIII, resulting in improvements in joint health scores; however, 44% still experienced some bleeding (ABR > 0) [44]. Here, F8 is linked to hemophilia.